1. MARKETS
  2. SECTOR : OTHERS
  3. INDUSTRY : OTHERS
  4. RAPPORT THERAPEUTICS INC.
Rapport Therapeutics Inc. XNAS: RAPP

Rapport Therapeutics Inc. Live Stock Price Today, Share Analysis and Chart

about

Rapport Therapeutics Inc is a clinical-stage biopharmaceutical company focused on discovery and development of transformational small-molecule medicines for patients suffering from central nervous system disorders. Its foundational science has elucid...

Read More
25.11 0.74 (3.04%)
40.60% Fall from 52W High
319.5K
XNAS Volume

XNAS 17 Nov, 2025 4:30 PM (EST)

Watchlist

Portfolio

Alert
Board Meeting
The latest board meeting for Rapport Therapeutics Inc. took place on 17 Nov 2025, for the purpose of Jefferies Global Healthcare Conference See details
Durability score
Not Eligible
Valuation Score
Expensive Valuation
8.3 / 100
Momentum Score
Technically Moderately Bullish
60.2 / 100
Analyst Price Target
No estimates available

13

S

5

W

6

O

0

T

SWOT Analysis

Rapport Therapeutics Inc Live Price Chart

Switch to TradingView


Loading Fundamental data..


Loading data..